Innovation Pharmaceuticals Inc (IPIX)

[sox040713]

OM will soon to be a billion dollar market and it's mostly untapped with just 5% of patients being prescribed for treatments. If top-line result shows 50% or higher prevention in severe OM, the FDA should grant BTD. A BTD designation would increase the odds of approval and decrease the time to approval. Why BPs won't be interested in an oral rinse drug which could dominate a billion dollar market?

The SP reached $1.08 after the very encouraging interim analysis. One week down and three more to go. Tick tock...

OM won't save 2017